Dr. Harold Paul Dietzius, MD

Dr. Dietzius practices at Carney Hospital (Closed) in Dorchester Center, Massachusetts.

Dr. Dietzius' NPI, 1649253790, was assigned on November 22, 2005. Dr. Dietzius graduated from University of Dublin Trinity College in 2002. Dr. Dietzius holds Florida license ME110096.

Dr. Dietzius' primary practice is Carney Hospital (Closed), at 2100 Dorchester Ave, Dorchester Center, MA 02124 in Suffolk County. The practice phone is (617) 506-2726.

Dr. Dietzius' primary practice is Carney Hospital (Closed) in Dorchester Center, Massachusetts. Dr. Dietzius is also affiliated with Massachusetts General Hospital. The medical group on file is Steward Medical Group. Dmand AI also links Dr. Dietzius to 3 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dietzius practices, 6 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Dietzius' primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Dietzius is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Dietzius' licenses on file in 3 states: Florida, Massachusetts and Pennsylvania.

Dmand AI lists aneurysm, atrial fibrillation and flutter, cardiomyopathy, cerebrovascular disease, chronic hypertension, coronary artery disease, heart failure and heart valve disorders among the conditions Dr. Dietzius treats.

CMS data shows 1,498 Medicare services from Dr. Dietzius across 17 procedure codes in 2024, for 706 Medicare patients. Medicare paid $79,293 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 706 Medicare patients who saw Dr. Dietzius in 2024. The largest group is 75 to 84, with 265 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 1.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dietzius' median patient age at 67, with 51% women.

In 2024, Dr. Dietzius wrote 2,378 Medicare Part D claims for 446 patients. 86% of them were for generic drugs. CMS names the drug for 2,189 of them, across 32 drugs with 11 or more claims each, at $304,803 in total drug cost. In 2023, CMS named 2,020 claims across 38 drugs.

Dr. Dietzius accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dietzius as offering telehealth.

Dmand AI links 3 papers to Dr. Dietzius, published from 2024 to 2025. Dr. Dietzius' most frequent co-authors are Ibrahim A. Kamel, MD, MHA, Saif Ibrahim, MD and Vasant Jayasankar, MD.

CMS Open Payments shows 165 general payments to Dr. Dietzius from 27 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Novartis Pharmaceuticals Corporation paid the most, $756.

Dmand AI lists 1 award for Dr. Dietzius.

Dr. Dietzius graduated from University of Dublin Trinity College in 2002. Dr. Dietzius is a member of ACC.

Dr. Dietzius is in network with 19 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.